Plasma levels and molecular forms of proatrial natriuretic peptides in healthy subjects and in patients with congestive heart failure

Journal of Endocrinology

Volumn 148, Issue 1, 1996, Pages 51-57

  Azizi, C ^a   Maistre, G ^a   Kalotka, H ^a   Isnard, R ^a   Barthelemy C ^a   Masson, F ^a   Pham, P ^b   Pousset, F ^a   Eurin, J ^a   Lechat, P ^a   Komajda, M ^a   Carayon, A ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b DIF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; FEMALE; HEART LEFT VENTRICLE FUNCTION; HUMAN; MALE; PRIORITY JOURNAL;

EID: 9044240036     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1480051     Document Type: Article

References (29)

1. Azizi C, Carayon A, Masson F, Noé E, Barthélemy C, Eurin J & Legrand JC 1993 Mechanisms of isoproterenol-induced atrial natriuretic peptide release from superfused rabbit atria. American Journal of Physiology 265 H1283-H1288.
2. Buckley MG, Sagnella GA, Markandu ND, Singer DR & MacGregor GA 1989 Immunoreactive N-terminal pro-atrial natriuretic peptide in human plasma: plasma levels and comparisons with α-human atrial natriuretic peptide in normal subjects, patients with essential hypertension, cardiac transplant and chronic renal failure. Clinical Science 77 573-579.
3. Chen Y-M, Whitson PA & Cintron NM 1990 Immunoreactive prohormone atrial natriuretic peptides 1-30 and 31-67: existence of a single circulating amino-terminal peptide. Biochemical and Biophysical Research Communications 166 794-800.
4. Currie MG, Geller DM, Cole BR, Siegel NR, Fok KF, Adams SP, Eubanks SR, Gallupi GR & Needleman P 1984 Purification and sequence analysis of bioactive atrial peptide. Science 233 67-69.
5. Dietz JR, Nazian SJ & Vesely DL 1991 Release of ANF, proANF 1-98, and proANF 31-67 from isolated rat atria by atrial distension. American Journal of Physiology 260 H1774-H1778.
6. Francis GS, Benedict C, Johnstone DE, Kirlin PC, Nicklas J, Liang C-S, Kubo SH, Rudin-Toretsky E, Yusuf S & Phil D 1990 Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the studies of left ventricular dysfunction (SOLVD). Circulation 82 1724-1729.
7. Gower WR Jr, Chiou S, Skolnick KA & Vesely DL 1994 Molecular forms of circulating atrial natriuretic peptides in human plasma and their metabolites. Peptides 15 861-867.
8. Itoh H, Nakao K, Mukoyama M, Sugawara A, Saito Y, Morii N, Yamada T, Shiono S, Arai H & Imura H 1988a Secretion of N-terminal fragment of γ-human atrial natriuretic polypeptide. Hypertension 11 I-52-I-56.
9. Itoh H, Nakao K, Sugawara A, Mukoyama SM, Mori N, Yamada T, Shiono S, Arai H, Hosoda K & Imura H 1988b γ-Atrial natriuretic polypeptide (γ-ANP)-derived peptides in human plasma: cosecretion of N-termmal γANP fragment and α-ANP. Journal of Clinical Endocrinology and Metabolism 67 429-437.
10. Lerman A, Gibbons RJ, Rodeheffer RJ, Bailey KR, Heublein DM & Burnett JC Jr 1993 Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left ventricular dysfunction. Lancet 341 1105-1109.
11. 2-terminal pro-ANP, and pressor hormones in anesthetized and conscious rats American Journal of Physiology 266 R1933-R1943.
12. Maki M, Takayanagi R, Misono KS, Pandey KN, Tibbetts C & Inagami T 1984 Structure of rat atrial natriuretic factor precursor deduced from cDNA sequence. Nature 309 722-724.
13. Mathiesen P, Hall C & Simonsen S 1993 Comparative study of atrial peptides ANF (1-98) and ANF (99-126) as diagnostic markers of atrial distension in patients with cardiac disease. Scandinavian Journal of Clinical Laboratory Investigation 53 41-49.
14. 2-terminal fragment of pro-hANF in essential hypertension. American Heart Journal 118 494-499.
15. Meleagros L, Ghatei MA, Gibbs JS & Bloom SR 1989 Pro-atrial natriuretic peptide (1-98): the circulating cardiodilatin in man. Peptides 10 545-550.
16. Ngo L, Bisset JK, Winters CJ & Vesely DL 1990 Plasma prohormone atrial natriuretic peptides 1-98 and 31-67 increase with supraventricular and ventricular arrhythmias. American Journal of Medicine and Science 300 71-77.
17. Ngo L, Vesely DL, Bisset JK, Murphy ML, Dinh HA, Sallman AL, Rico DM, Winters CJ & Wyeth RP 1991 Acute and sustained release of the atrial natriuretic factor prohormone N-terminus with acute myocardial infarction. American Journal of Medicine and Science 301 157-164.
18. Pham P, Rammobordes C, Perret C, Ronco P, Budisavljevic M, Verroust P & Beaucourt JP 1991 Radiolabelling by tritium and I-iodine of an angiotensin II related peptide. Journal of Labelled Compounds and Radiophamaceuticals 29 575-581.
19. Sundsfjord JA, Thibault G, Larochelle P & Cantin M 1988 Identification and plasma concentrations of the N-terminal fragment of proatrial natriuretic factor in man. Journal of Clinical Endocrinology and Metabolism 66 605-610.
20. 2-terminal fragment of rat pro-atrial natriureac factor in the circulation: identification, radioimmunoassay and half-life. Peptides 9 47-53.
21. Vesely DL & Winters CJ 1990 Presence of the N-terminal and C-terminal portions of the prohormone of atrial natriuretic factor in the ascitic fluid of cirrhotic patients. Journal of Medicine 21 265-275.
22. Vesely DL, Norris JS, Walters MJ, Jespersen RR & Baeyens DA 1987 Atrial natriuretic prohormone peptides 1-30, 31-67, and 79-98 vasodilate the aorta. Biochemical and Biophysical Research Communications 148 1540-1548.
23. Vesely DL, Cornett LE, MacLeod SL, Nash AA & Norris JS 1990 Specific binding sites for prohormone atrial natriuretic peptides 1-30, 31-67 and 99-126. Peptides 11 193-197.
24. Vesely DL, Douglass MA, Dietz JR, Gower WR Jr, McCormick MT, Rodriguez-Paz G & Schocken DD 1994 Three peptides from the atrial natriuretic factor prohormone amino terminus lower blood pressure and produce a diuresis, natriuresis, and/or kaliuresis in humans. Circulation 90 1129-1140.
25. Weir ML, Honrath U, Flynn TG & Sonnenberg H 1994 Lack of biologic activity or specific binding of amino-terminal pro-ANP segments in the rat. Regulatory Peptides 53 111-122.
26. Winters CJ, Sallman AL, Meadows J, Rico DM & Vesely DL 1988 Two new hormones: prohormone atrial natriuretic peptides 1-30 and 31-67 circulate in man. Biochemical and Biophysical Research Communications 150 231-236.
27. Wynne J, Green LH, Mann T, Levin D & Grossman W 1978 Estimation of left ventricular volumes in man from biplane cineangiograms filmed in oblique projections. American Journal of Cardiology 41 726-732.
28. Yamanaka M, Greenberg B, Johnson L, Seilhamer J, Brewer M, Friedemann T, Miller J, Atlas S, Laragh J, Lewicki J & Fiddes J 1984 Cloning and sequence analysis of the cDNA for the rat atrial natriuretic factor precursor. Nature 309 719-722
29. Zongazo MA, Carayon A, Masson F, Isnard R, Eunn J, Maistre G, Barthélemy C, Prost A, Landault C & Legrand JC 1992 Atrial natriuretic peptide during deprivation or hemorrhage in rats: Relationship with arginine vasopressin. Journal of Physiology 86 167-175.